La inclinación del eje terrestre es un fenómeno fascinante que tiene profundos efectos sobre nuestro planeta. Esta inclinación no solo es responsable de las estaciones del año, sino que también influye en el clima, las corrientes oceánicas y la biodiversidad …
La inclinación del eje terrestre: Causas y consecuencias para nuestro planeta Read More »
Empédocles, una figura emblemática de la antigua Grecia, dejó una huella indeleble en el ámbito de la filosofía, la ciencia y el misticismo. Nacido en Akragas, una ciudad próspera en la isla de Sicilia, alrededor del año 490 a.C., Empédocles es …
Empédocles: El filósofo, científico y místico de la antigua Grecia Read More »
Yellowstone Biosciences, a pioneer of soluble bispecific T-cell receptor -based therapies for human leukocyte antigen Class II targets in oncology, launches to unlock a new class of therapeutically targetable, frequently expressed antigens with potential to significantly transform patient lives.
bit.bio, the company coding human cells for novel cures and a pioneer in the field of synthetic biology, announces the launch of ioAstrocytes.
bit.bio Launches ioAstrocytes, Advancing How Scientists Can Model the Human Brain Read More »
The Lupus Research Alliance announced the recipients of the 2024 Lupus Insight Prize to Marko Radic, Ph.D., The University of Tennessee Health Science Center, and Georg Schett, M.D., Friedrich-Alexander-Universität Erlangen-Nürnberg, for their groundbreaking discoveries in utilizing CAR T cell therapy to potentially revolutionize lupus treatment.
PureTech Health plc, a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, announces that Raju Kucherlapati, PhD, has been appointed Chair of the Board of Directors, effective immediately, following his role as interim Chair since June 2023.
Biophytis SA announces the signature of an exclusive license agreement with Blanver, one of the leading and most trusted pharmaceutical company in Brazil, for BIO101 in Latin American including, but not limited to Brazil, Mexico, Argentina and Colombia.
MorphoSys AG announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo Germany AG.
Sensorion announces that promising new data and analysis results from the SENS-401 following cochlear implantation Phase 2a clinical study will be presented at the 17th International Conference on Cochlear Implants and Other Implantable Technologies taking place on July 10-13, 2024, in Vancouver, Canada.
GenSight Biologics announced the renegotiation of certain financial obligations, securing its financial position and improving short-term flexibility.
GenSight Biologics Renegotiates Financial Obligations and Provides Operational Updates Read More »
